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REPORTS 
DNA Aneuploidy in Congenital Melanocytic Nevi: Suggestive Evidence 
for Premalignant Changes 
WERNER STENZINGER, M.D., LUDWIG SUTER, M.D ., AND JOHANNES SCHUMANN, PH.D. 
Fachhlinih Hornheide, West{iilische Wilh.elms-Un.iversitiit, Munster, F.R.G. 
Nuclei with abnormal (aneuploid) DNA content were 
detected by flow cytometric analysis in 4 of 39 congen-
ital melanocytic nevi and in 0 of 62 acquired nevi. Three 
of the 4 nevi with DNA-aneuploidy were greater than 
20 em in their largest diameter. We suggest that DNA 
aneuploidy is an indicator of a premalignant condition 
in congenital nevi in cases where histologic examination 
does not reveal any evidence for malignant melanoma. 
Cells with abnormal DNA content (aneuploid cells) are 
not uniformly distributed in giant congenital nevi: in 
one lesion we observed an area with a high percentage 
of cells with DNA aneuploidy, areas with a low percent-
age of aneuploid cells, and parts that were found to be 
normal by flow cytometric analysis. Nuclear pleomorph-
ism was found histologically in the area with the high 
percentage of aneuploid cells while the areas with the 
low percentage of aneuploid cells were histologically 
normal. Thus, flow cytometry seems to be an additional 
sensitive method for the detection of nuclear abnormal-
ities that are not always apparent by conventional his-
tology. 
Increase in the relative amount of growth phase (S-
phase cells), indicating elevated proliferative activity, 
was detected in 6 of 39 congenital pigmented nevi and 
in 6 of 62 acquired nevocellular nevi. 
The possibili ty that a gian t melanocytic nevus will become 
malignant during a lifetime is at least 6.3 % [1], while fo r small 
congenita l nevi the risk of melanoma to age 60 years has been 
estimated to be as high as 4.9% [2]. Therefo re, at least some 
congeni tal mela nocytic nevi may be regarded as premalignant 
les ions [3]. It would be desirable to have phenotypic markers 
fo r the detection of premalignant changes in congen ital nevi. 
This wou ld be helpful in t he s tudy of clinical features associated 
with premaligna ncy in these lesions. 
Some a u thors [3,4 ] have suggested estrogen binding activity 
as s uch a phenotypic marker. 
We have applied !low cytometry (FCM) to t his problem. By 
FCM t he DNA conten t of tens of t housands of ce lls can be 
determin ed in a few minu tes. DNA -distribution curves are 
automatica lly plotted and a na lyzed by a computer. This method 
accurately detects a bnormalities of cell nuclei in ma ligna nt 
tumors l5-8]. Our results suggest that FCM is a lso suitable for 
t he detection of certai n premalignan t co ndi tions in congenital 
melanocytic nev i. 
MATERIALS AND METHODS 
Adjacent 1- 3 mm thick tissue sections from the same congeni tal 
melanocytic nevus were used for FCM and for convent ional histology. 
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For FCM, normally less than 1-mm" excision material is needed. This 
minimal amount, however, was employed in only one case in order to 
contirm DNA aneuploidy in an extremely small piece of tissue with 
normal histology. The material was minced with surgical blades and 
afterwards stirred on a magnetic stirrer in a 0.5% pepsin solution to 
get a si ngle-cell suspension. This single-cell suspension was stained 
with a mixture of the fluorescent dyes ethidim:nbromide and mithra -
mycin according to the Zante protocol [8]. The stained cell suspension 
was run through a pulse-cytophotometer (ICP-type) with a special glass 
flow-through chamber designed by Giihde [6]. Abnormal DNA stem-
lines were confirmed by admixing normal skin cells from the same 
patient as diploid reference cells. When diffe rent DNA stemlines were 
detected in different specimens from the same nevus, an addi tional 
control, made by mixing all samples from this nevus, was included. 
Flow cytometry allows the detection of abnormal DNA stemlines-
corresponding to aneuploid cells with high accuracy. However, sin ce 
this aneuploidy has not yet been confirmed by chromosome analysis, 
the te rms DNA aneuploidy or abnormal DNA stemline are used. 
Specimens were obtained in a co nsecut ive manner, based on logis-
t ical considerations. Both congenita l and acquired lesions were excised 
for cosmetic reasons, atypical gross appearance, and for other reasons 
that were not always apparent to the investigators. 
RESULTS 
Histopathology 
The majority of nev i classified as congenital by hi story (typ-
ica l appearance of a large nevus is s hown in Fig 1) fulfilled 
FIG 1. Giant congeni tal nevus of the child J.L. 
TABLE I. Histologic features of congenital melanocytic nevi (number of 
positive/number of examined) 
S ize (l a rgest diameter) 
Nevus ce lls 
In lowe r der-
mis s ingly or 
in t iers be-
tween co ll agen 
bundles 
In epide rmal N uclea r . 
appendages or p leomorph- M1t.oses 
walls of blood •sm 
vessels 
Small (1.4 em or less) 3/11 4/11 0/ 11 0/ 11 
Medium (1.5-19.9 em) 19/ 25 14/25 0/25 0/25 
Large (20 em or more) 3/3 3/3 1/3 1/ 3 ~--~--------~------~----~ 
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FIG 2. Gianl congenital nevus J.L. Histologic and flow cytometric 
findin gs. A, Nevus cells in the lower dermis arranged in single fi le and 
present in t he wa ll of 2 blood vessels, especially in t he lower left corner. 
Bar = 0.1 mm. B, Nodular area wi th pleomorphic cells. Contact of 
tumor cells with t he epidermis was not observed in any parL of t he 
nodule. No inflammatory infil trate was present . Ba.r = 0.1 mm. C, DNA 
histogram of t he area shown in (B ). Abscissa: relative fluorescence 
values. Ordinate: number of measured cells per channel. The first peak 
represents ce lls with dip loid DNA conte nt (DNA index 2.0). The second 
peak represents cells with abnormal G1/G 0 DNA content . T he DNA 
index of this ce ll line is 2.8. T he abnormal DNA stemline (about 63% 
histologic cri te ria known to be typical fo r con ge ni tal pigmen ted 
lesions [9): in 25 of 39 cases nevus cells were observed in t he 
lower two-thirds of t he stratum reticula re a nd often a lso in t he-
subcutaneous fat (T able 1). N evus cells in the lower dermi s 
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of Lhe sample) shows a relative ly high amoun t of ce lls in the S-phase 
region (19.0%). D, Flat area. No cellular or nuclear pleomorphism as 
in (B) was detectable. Nevus cells are arranged in nests in the upper 
dermis. Bar= 0. 1 mm. E, DNA histogram of t he area shown in (D). 
Abscissa: relative fluorescence values. Ordinate: number of measured 
cells per chan nel. The diagram without bars right of the first peak 
shows a 4 times enlarged part of the histogram. The first peak repre-
sents cells wi th diploid DNA content (DNA index 2.0). The first peak 
in the enlarged part represents a cell line wit h abnormal DN A content 
(DNA index 2.5), about 1.4 % of the sample; the second peak in the 
enlarged part consists of G2 + M cells of the di ploid cell line. 
were di sposed between t he collagen bundles s ingly o r in single 
fi le or bot h (Fig 2A ). In 21 of t he 39 nevi known by hi story to 
be con genital, n evus cells were found in blood vessels and in 
skin appendages , predomina n t ly in musculi a rrectores pilorum 
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but a lso in sweat glands, sebaceous glands, and hair follicl es. 
C h aracte ri stic hi sto logic features of congeni tal nevi were more 
often observed in les ions greater t han 1.5 em in their largest 
diam eter compa red to smaller ones (Table I). In one gian t 
co n geni ta l nevus (Fig 2B) pleomorphism of cell s and nucle i 
a nd a few mitoses were found in the absence of any histologic 
e vide nce fo r melanoma. These abnormalities were confined to 
t he d e rmi s of a sma ll nodular part while t he rest of the lesion 
was norma l. 
Flow Cy tometry 
Abnormal DNA stem lines were detected in 4 of 39 congeni tal 
m e lanocytic nevi and in 0 of 62 acquired nevocellula r nevi 
(T ab le li ). Three of t he lesions wi t h abnormal DNA stemlines 
were greater t han 20 em in t heir largest diameter. In these 4 
cases, multiple specimens from the same nevus were examined 
in 3 patients (Table III) . In 2 congenital nevi , 2 differen t 
abnorma l DNA stemlines could be found (in nevus J.L. with 
DNA index 2.5 and 2.8, in nevus L.N. with DNA index 2.7 and 
3.2) . The relative amoun t of cell s with abnormal DNA content 
varied from 0.25 % in sample #2 of nevus P .U., to 63 % in sample 
#1 of nevus J.L. (Table III) . 
The 4 nev i of DNA aneuploidy had typical histologic features 
of con genita l melanocytic nevi. . . . 
The most impressive abnormal DNA -d1stnbut10n pattern 
was o bse rved in a small nodule of the giant congenital nevus 
J.L., which on histologic examination showed ple~morp~onu­
clear cell s a nd a few mitoses (Fig 2B,C). Some histologically 
norma l parts of the same lesion (Fig 2D) a lso contained an 
abnormal DNA stemline- however, having another DNA index 
TABLE II . Pulse cytophotometric examination of congenital and 
acquired nevi (number of po~itiuefnum.ber of tested) 
Aneuploidy More than 10% of cells in S phase" 
Con genital nevocellular nevi 
S m a ll (1.4 ern or Jess) 0/11 3/ 11 
Medium (1.5- 19.9 em) 1/25 1/ 25 
Large (20 em or more) 3/3 2/3 
T ota l 4/39 6/ 39 
Acquired nevocellular nevi 0/62 6/62 
- .- If several sa mples were analyzed from the same nevus, only the 
highest value was used for this calcu lation. 
value (Fig 2E, Table III )- while 4 other parts had a "normal" 
DNA distribu tio n (Table III) . 
Increased proliferative activity of t he cells-i .e., more than 
10% of the cells in t he S-phase region of the DNA histogram-
was detected in 6 of 39 congeni tal melanocytic nevi and in 6 of 
62 acquired nevi. DNA aneupl oidy was not always correlated 
with a higher relative amoun t of S-phase cells. Four of the 6 
acquired nevi with increased rates o f S-phase cells were from 
t he face, 1 was from the s houlder, and 1 was from the nec k. 
Three of t he 6 acquired nevi with increased ra tes o f S-phase 
cell s had atypical features (irregu la r borders and co lor pattern). 
In 1 o f t hese 3 nevi , atyp ica l melanocytic hyperplasia was found 
by his to logic examination . The other 3 acquired nevi with 
increased rates of S-phase cells had a normal gross appearance. 
One of t hese lesions was excised because of previous increase 
in s ize and 2 because of t heir localization on t he upper lip and 
eyelid, which was irri tati ng for t he patient. 
DISCUSSION 
By flow cytometry we have demonstrated DNA aneuploidy 
as a ma rked abnormality of nuclei in 4 of 39 congen ital melan -
ocytic nevi . DNA aneuploidy was not found in 62 acquired nev i. 
In a la rger series [7) DNA aneuploidy has been detected in 
91 % of specimens from ma lignan t tumors. In addition, DNA 
aneuploidy was found in 9 histologically normal t issue samples 
t hat were obtained from patients wi th prev ious (7 pat ien ts) or 
subsequent (2 patien ts) histologic evidence of malignancy. 
DNA aneuploidy cou ld a lso be detected in severe cervical 
dysplas ia. Thus, DNA aneuploidy is regarded as a se ns itive 
marker of ma ligna ncy that a lso occurs in certain premaligna nt 
conditions where t he carcinogenic process has passed ce rtain 
ba rriers and is likely to progress to invasion [10,11]. DNA 
aneuploidy has a lso been observed in 4 of 9 benign monoclona l 
ga mmopathies [1 2]. Since progress ion of benign monoclona l 
gammopa thies into malignant d isease is known , these "benign" 
cases may indeed have been premalignant conditions not de-
tectable by co nve ntiona l histology. Since the increased rate of 
ma li gnant melanoma developing in congenital melanocytic nevi 
compared to acquired nevi [3, 13) is well known , we would 
suggest, that DNA aneuploidy in congenital nevi as desc ribed 
in t his study is an indicato r of a premalignant condi t ion 
because melanoma could be excluded by histologic examinati 01~ 
in these cases and no aneuploidy could be detected in 62 
acquired nevi. 
TABLE III. Congenital nevi with aneuploidy 
Patients 
J.L. 
M.M. 
P.U. 
L.N. 
Sex 
F 
F 
F 
F 
Age 
1 
19 
55 
20 
"DNA index of diploid cells= 2.0. 
Size of lesion (em ) Loca lization 
26.0 X 23.5 Back 
21.5 X 18.5 Back 
:3 .3 X 1.6 Back 
27.0 X 22.0 Back 
" n .d. =the percentage could not be calculated from the histogram. 
Specimen no. 
I 
2 
3 
4 
5 
6 
1 
2 
2 
3 
4 
5 
6 
7 
8 
9 
10 
DNA index• Percent of aneu- Percent of S-plaid cells phase cells 
2.8 63 18.3 
2.0 0 14.2 
2.0 0 15.7 
2.5 1.4 12.2 
2.0 0 16.8 
2.0 0 10.1 
3.1 29.8 3.98 
3.4 0.4 4.45 
3.4 0.25 3.58 
2.7 4.7 n.d. " 
2.7 5.4 38.2 
2.7 5.1 40.0 
2.0 0 14.9 
2.0 0 14.6 
3.2 2.4 n.d. 
2.0 0 8.64 
2.0 0 6.22 
2.0 0 7.29 
2.0 0 n.d. 
572 STENZIN GER, SUTER, AND SCHU MANN 
In our study, in on ly 1 specimen- a nodule from a giant 
congen ita l nevus- was DNA aneuploidy associated wit h his-
to logic abnormalities of dermal nevus ce lls, a moderate degree 
of nuclear pleomorphism, and a few mitoses. All other nevi 
with DNA aneuploidy were normal on histologic examination . 
It is unlikely that sampling biases are t he reason for t his 
difference between histology and FCM, because histologic and 
pulse cytophotometric examination were performed on adjacen t 
1- 3 rom-thick t issue sections. 
In one case involving differences between histology and FCM, 
both methods were performed on small parts of t he same 0.5-
1-mm" t issue section. This difference, normal histology a nd 
FCM wit h DNA aneuploidy, indicates t hat FCM can reveal 
subtle nuclear abnormali t ies t hat may be undetectable by con-
ventional hi stologic examination. On t he other hand, abnormal 
cells can be more easily and more accurately localized by 
histo logy; in ou r study employing minced t issue samples, epi-
dermal and dermal nevus cells and melanocytes could not be 
separately a nalyzed by FCM. 
We need add itiona l data to calculate t he relative frequency 
of nuclear abnormalities in congenital melanocytic nevi. A 
higher percentage of DNA aneuploidy was found in giant con-
genital nevi with a diameter of more t ha n 20 em compared to 
smaller ones. Sampling biases a re not responsible for t his 
difference because we have advised excision of all congen ital 
nevi, irrespective of their gross appearance. However, t he num-
ber of t he congen ital nevi with a diamete r of more t han 20 em 
was too small in our series to generalize our findings. 
T here is still some cont roversy as to whether one should 
advise excision of a ll congenital melanocytic nevi, irrespective 
of their s ize [1 ,3,14]. We would argue in favor of t he removal 
of a ll congenita l melanocytic nevi on t he basis of our FCM data 
suggesting premalignant changes even in a lesion of 3.3 x 1.6 
em. Unfortunately, a s ingle biopsy will not be su fficient to 
exclude DNA aneuploidy in a giant congeni tal nevus: in one 
congeni tal nevus we found areas with a high percentage of cells 
with abnormal DNA conte nt besides t hose t hat were normal 
on FCM examination. It remains to be determined in the future 
whether areas in a congen ital nevus with certain clinical fea-
tures (nodules, irregularities of color, localization) a re more 
likely to be associated wit h DNA aneuploidy. 
Increase in the relative amount of cells in the S-phase region 
of t he cell cycle, indicating higher proliferative activity, was 
observed in some congeni tal pigmented nevi. Increased prolif-
erative activity is not a specific feature of malignant and 
premalignant tu mors [5- 8] and was fo und in our series a lso in 
6 acquired nevi. 
F low cytometry can detect ce rtain DNA abnormali t ies asso-
ciated with malignant or premalignant conditions with great 
precision. However, DNA aneup loidy is on ly one marker of 
malignancy or premalignancy and may even be absen t in a 
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certain percentage of ma ligna nt tumors that appear unsuspi-
cious on FCM a nalyses [7]. T he knowledge of addit iona l mark: 
ers associated with malignant and premalignant lesions and 
methods for t heir determination is, t herefore, desirable. Even-
tually, immunohistoiogy with monoclonal an tibodies will brin<Y 
some p rogress here. b 
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